A detailed history of Massachusetts Financial Services CO transactions in Biogen Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 711,184 shares of BIIB stock, worth $106 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
711,184
Previous 548,673 29.62%
Holding current value
$106 Million
Previous $127 Million 8.38%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $30.7 Million - $38.5 Million
162,511 Added 29.62%
711,184 $138 Million
Q2 2024

Aug 09, 2024

SELL
$190.52 - $236.72 $5.01 Million - $6.23 Million
-26,302 Reduced 4.57%
548,673 $127 Million
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $1.08 Million - $1.36 Million
-5,090 Reduced 0.88%
574,975 $124 Million
Q4 2023

Feb 08, 2024

BUY
$222.59 - $267.94 $29.7 Million - $35.8 Million
133,463 Added 29.88%
580,065 $150 Million
Q3 2023

Nov 08, 2023

BUY
$253.3 - $285.89 $76 Million - $85.8 Million
300,086 Added 204.81%
446,602 $115 Million
Q2 2023

Aug 09, 2023

SELL
$275.25 - $318.06 $157,167 - $181,612
-571 Reduced 0.39%
146,516 $41.7 Million
Q1 2023

May 10, 2023

SELL
$256.56 - $292.34 $118,530 - $135,061
-462 Reduced 0.31%
147,087 $40.9 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $20.3 Million - $24.7 Million
-80,471 Reduced 35.29%
147,549 $40.9 Million
Q3 2022

Nov 09, 2022

BUY
$194.69 - $268.46 $10.9 Million - $15 Million
55,837 Added 32.43%
228,020 $60.9 Million
Q2 2022

Aug 09, 2022

SELL
$187.54 - $223.02 $6.26 Million - $7.44 Million
-33,373 Reduced 16.24%
172,183 $35.1 Million
Q1 2022

May 11, 2022

SELL
$193.77 - $244.14 $772,560 - $973,386
-3,987 Reduced 1.9%
205,556 $43.3 Million
Q4 2021

Feb 10, 2022

BUY
$223.92 - $287.77 $1.25 Million - $1.6 Million
5,561 Added 2.73%
209,543 $50.3 Million
Q3 2021

Nov 10, 2021

BUY
$282.99 - $369.05 $29.7 Million - $38.7 Million
104,969 Added 106.02%
203,982 $57.7 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $16.5 Million - $26.4 Million
63,556 Added 179.25%
99,013 $34.3 Million
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $8.33 Million - $9.76 Million
-34,295 Reduced 49.17%
35,457 $9.92 Million
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $12.3 Million - $18.5 Million
-52,098 Reduced 42.76%
69,752 $17.1 Million
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $17 Million - $19.7 Million
-64,338 Reduced 34.56%
121,850 $34.6 Million
Q2 2020

Aug 11, 2020

SELL
$258.66 - $342.55 $9.31 Million - $12.3 Million
-35,986 Reduced 16.2%
186,188 $49.8 Million
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $21.1 Million - $26.8 Million
-78,559 Reduced 26.12%
222,174 $70.3 Million
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $34.8 Million - $48.1 Million
-158,343 Reduced 34.49%
300,733 $89.2 Million
Q3 2019

Nov 05, 2019

SELL
$217.44 - $243.88 $95.7 Million - $107 Million
-440,319 Reduced 48.96%
459,076 $107 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $205 Million - $226 Million
-934,178 Reduced 50.95%
899,395 $210 Million
Q1 2019

May 13, 2019

SELL
$216.71 - $338.96 $16.5 Million - $25.8 Million
-75,998 Reduced 3.98%
1,833,573 $433 Million
Q4 2018

Feb 08, 2019

BUY
$278.5 - $352.75 $13.1 Million - $16.6 Million
47,142 Added 2.53%
1,909,571 $575 Million
Q3 2018

Oct 25, 2018

SELL
$293.51 - $383.83 $68.3 Million - $89.3 Million
-232,576 Reduced 11.1%
1,862,429 $658 Million
Q2 2018

Jul 30, 2018

BUY
$257.52 - $306.91 $4.84 Million - $5.77 Million
18,790 Added 0.91%
2,095,005 $608 Million
Q1 2018

May 04, 2018

BUY
$260.13 - $367.91 $64.1 Million - $90.7 Million
246,436 Added 13.47%
2,076,215 $569 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $11.7 Million - $13.1 Million
37,909 Added 2.12%
1,829,779 $583 Million
Q3 2017

Nov 14, 2017

SELL
$281.15 - $329.69 $13.4 Million - $15.7 Million
-47,712 Reduced 2.59%
1,791,870 $561 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,839,582
1,839,582 $499 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.